Clinical stability after compassionate use of intranasal esketamine in treatment-resistant depression

INTRODUCTION: The compassionate use of intranasal esketamine is approved in Spain for treatment-resistant depression (TRD). OBJECTIVES: The objective of the study is to assess the clinical stability in the medium-term follow-up of patients with TRD after esketamine use. METHODS: Descriptive, retrosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hernandez Huerta, D., De Santiago Diaz, A., Rodriguez Gomez-Carreño, C., Abril Garcia, M.A., Toledo Romero, F., Guerrero Morcillo, A., Martinez Pastor, C.J., Vega Piñero, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566242/
http://dx.doi.org/10.1192/j.eurpsy.2022.762

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9566242/
http://dx.doi.org/10.1192/j.eurpsy.2022.762

Ejemplares similares